Reviews Haloperidol Decanoate


No reviews yet.

Haldol Decanoate Drug Description
HALDOL® Decanoate 50
(haloperidol decanoate)
HALDOL® Decanoate 100
(haloperidol decanoate)

WARNING
Increased Mortality in Elderly Patients with Dementia-Related Psychosis:
Elderly patients with dementia-related psychosis treated with antipsychotic
drugs are at an increased risk of death. Analyses of seventeen placebo-controlled
trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic
drugs, revealed a risk of death in drug-treated patients of between 1.6 to
1.7 times the risk of death in placebo-treated patients. Over the course of
a typical 10 week controlled trial, the rate of death in drug-treated patients
was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although
the causes of death were varied, most of the deaths appeared to be either
cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia)
in nature. Observational studies suggest that, similar to atypical antipsychotic
drugs, treatment with conventional antipsychotic drugs may increase mortality.
The extent to which the findings of increased mortality in observational studies
may be attributed to the antipsychotic drug as opposed to some characteristic(s)
of the patients is not clear. HALDOL Decanoate is not approved for the treatment
of patients with dementia-related psychosis (see WARNINGS).

DRUG DESCRIPTION
Haloperidol decanoate is the decanoate ester of the butyrophenone, HALDOL (haloperidol). It has a markedly extended duration of effect. It is available in sesame oil in sterile form for intramuscular (IM) injection. The structural formula of haloperidol decanoate, 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4 piperidinyl decanoate, is:








Haloperidol decanoate is almost insoluble in water (0.01 mg/mL), but is soluble in most organic solvents.
Each mL of HALDOL Decanoate 50 for IM injection contains 50 mg haloperidol
(present as haloperidol decanoate 70.52 mg) in a sesame oil vehicle, with 1.2%
(w/v) benzyl alcohol as a preservative.
Each mL of HALDOL Decanoate 100 for IM injection contains 100 mg haloperidol (present as haloperidol decanoate 141.04 mg) in a sesame oil vehicle, with 1.2% (w/v) benzyl alcohol as a preservative.
Last reviewed on RxList: 10/17/2008




Haldol Decanoate Drug Description
HALDOL® Decanoate 50
(haloperidol decanoate)
HALDOL® Decanoate 100
(haloperidol decanoate)

WARNING
Increased Mortality in Elderly Patients with Dementia-Related Psychosis:
Elderly patients with dementia-related psychosis treated with antipsychotic
drugs are at an increased risk of death. Analyses of seventeen placebo-controlled
trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic
drugs, revealed a risk of death in drug-treated patients of between 1.6 to
1.7 times the risk of death in placebo-treated patients. Over the course of
a typical 10 week controlled trial, the rate of death in drug-treated patients
was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although
the causes of death were varied, most of the deaths appeared to be either
cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia)
in nature. Observational studies suggest that, similar to atypical antipsychotic
drugs, treatment with conventional antipsychotic drugs may increase mortality.
The extent to which the findings of increased mortality in observational studies
may be attributed to the antipsychotic drug as opposed to some characteristic(s)
of the patients is not clear. HALDOL Decanoate is not approved for the treatment
of patients with dementia-related psychosis (see WARNINGS).

DRUG DESCRIPTION
Haloperidol decanoate is the decanoate ester of the butyrophenone, HALDOL (haloperidol). It has a markedly extended duration of effect. It is available in sesame oil in sterile form for intramuscular (IM) injection. The structural formula of haloperidol decanoate, 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4 piperidinyl decanoate, is:








Haloperidol decanoate is almost insoluble in water (0.01 mg/mL), but is soluble in most organic solvents.
Each mL of HALDOL Decanoate 50 for IM injection contains 50 mg haloperidol
(present as haloperidol decanoate 70.52 mg) in a sesame oil vehicle, with 1.2%
(w/v) benzyl alcohol as a preservative.
Each mL of HALDOL Decanoate 100 for IM injection contains 100 mg haloperidol (present as haloperidol decanoate 141.04 mg) in a sesame oil vehicle, with 1.2% (w/v) benzyl alcohol as a preservative.
Last reviewed on RxList: 10/17/2008




Haldol Decanoate Drug Description
HALDOL® Decanoate 50
(haloperidol decanoate)
HALDOL® Decanoate 100
(haloperidol decanoate)

WARNING
Increased Mortality in Elderly Patients with Dementia-Related Psychosis:
Elderly patients with dementia-related psychosis treated with antipsychotic
drugs are at an increased risk of death. Analyses of seventeen placebo-controlled
trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic
drugs, revealed a risk of death in drug-treated patients of between 1.6 to
1.7 times the risk of death in placebo-treated patients. Over the course of
a typical 10 week controlled trial, the rate of death in drug-treated patients
was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although
the causes of death were varied, most of the deaths appeared to be either
cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia)
in nature. Observational studies suggest that, similar to atypical antipsychotic
drugs, treatment with conventional antipsychotic drugs may increase mortality.
The extent to which the findings of increased mortality in observational studies
may be attributed to the antipsychotic drug as opposed to some characteristic(s)
of the patients is not clear. HALDOL Decanoate is not approved for the treatment
of patients with dementia-related psychosis (see WARNINGS).

DRUG DESCRIPTION
Haloperidol decanoate is the decanoate ester of the butyrophenone, HALDOL (haloperidol). It has a markedly extended duration of effect. It is available in sesame oil in sterile form for intramuscular (IM) injection. The structural formula of haloperidol decanoate, 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4 piperidinyl decanoate, is:








Haloperidol decanoate is almost insoluble in water (0.01 mg/mL), but is soluble in most organic solvents.
Each mL of HALDOL Decanoate 50 for IM injection contains 50 mg haloperidol
(present as haloperidol decanoate 70.52 mg) in a sesame oil vehicle, with 1.2%
(w/v) benzyl alcohol as a preservative.
Each mL of HALDOL Decanoate 100 for IM injection contains 100 mg haloperidol (present as haloperidol decanoate 141.04 mg) in a sesame oil vehicle, with 1.2% (w/v) benzyl alcohol as a preservative.
Last reviewed on RxList: 10/17/2008




Haldol Decanoate Drug Description
HALDOL® Decanoate 50
(haloperidol decanoate)
HALDOL® Decanoate 100
(haloperidol decanoate)

WARNING
Increased Mortality in Elderly Patients with Dementia-Related Psychosis:
Elderly patients with dementia-related psychosis treated with antipsychotic
drugs are at an increased risk of death. Analyses of seventeen placebo-controlled
trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic
drugs, revealed a risk of death in drug-treated patients of between 1.6 to
1.7 times the risk of death in placebo-treated patients. Over the course of
a typical 10 week controlled trial, the rate of death in drug-treated patients
was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although
the causes of death were varied, most of the deaths appeared to be either
cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia)
in nature. Observational studies suggest that, similar to atypical antipsychotic
drugs, treatment with conventional antipsychotic drugs may increase mortality.
The extent to which the findings of increased mortality in observational studies
may be attributed to the antipsychotic drug as opposed to some characteristic(s)
of the patients is not clear. HALDOL Decanoate is not approved for the treatment
of patients with dementia-related psychosis (see WARNINGS).

DRUG DESCRIPTION
Haloperidol decanoate is the decanoate ester of the butyrophenone, HALDOL (haloperidol). It has a markedly extended duration of effect. It is available in sesame oil in sterile form for intramuscular (IM) injection. The structural formula of haloperidol decanoate, 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4 piperidinyl decanoate, is:








Haloperidol decanoate is almost insoluble in water (0.01 mg/mL), but is soluble in most organic solvents.
Each mL of HALDOL Decanoate 50 for IM injection contains 50 mg haloperidol
(present as haloperidol decanoate 70.52 mg) in a sesame oil vehicle, with 1.2%
(w/v) benzyl alcohol as a preservative.
Each mL of HALDOL Decanoate 100 for IM injection contains 100 mg haloperidol (present as haloperidol decanoate 141.04 mg) in a sesame oil vehicle, with 1.2% (w/v) benzyl alcohol as a preservative.
Last reviewed on RxList: 10/17/2008




Haldol Decanoate Drug Description
HALDOL® Decanoate 50
(haloperidol decanoate)
HALDOL® Decanoate 100
(haloperidol decanoate)

WARNING
Increased Mortality in Elderly Patients with Dementia-Related Psychosis:
Elderly patients with dementia-related psychosis treated with antipsychotic
drugs are at an increased risk of death. Analyses of seventeen placebo-controlled
trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic
drugs, revealed a risk of death in drug-treated patients of between 1.6 to
1.7 times the risk of death in placebo-treated patients. Over the course of
a typical 10 week controlled trial, the rate of death in drug-treated patients
was about 4.5%, compared to a rate of about 2.6% in the placebo group. Although
the causes of death were varied, most of the deaths appeared to be either
cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia)
in nature. Observational studies suggest that, similar to atypical antipsychotic
drugs, treatment with conventional antipsychotic drugs may increase mortality.
The extent to which the findings of increased mortality in observational studies
may be attributed to the antipsychotic drug as opposed to some characteristic(s)
of the patients is not clear. HALDOL Decanoate is not approved for the treatment
of patients with dementia-related psychosis (see WARNINGS).

DRUG DESCRIPTION
Haloperidol decanoate is the decanoate ester of the butyrophenone, HALDOL (haloperidol). It has a markedly extended duration of effect. It is available in sesame oil in sterile form for intramuscular (IM) injection. The structural formula of haloperidol decanoate, 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4 piperidinyl decanoate, is:








Haloperidol decanoate is almost insoluble in water (0.01 mg/mL), but is soluble in most organic solvents.
Each mL of HALDOL Decanoate 50 for IM injection contains 50 mg haloperidol
(present as haloperidol decanoate 70.52 mg) in a sesame oil vehicle, with 1.2%
(w/v) benzyl alcohol as a preservative.
Each mL of HALDOL Decanoate 100 for IM injection contains 100 mg haloperidol (present as haloperidol decanoate 141.04 mg) in a sesame oil vehicle, with 1.2% (w/v) benzyl alcohol as a preservative.
Last reviewed on RxList: 10/17/2008





Other reviews about Haloperidol Decanoate on wordpress

What Is Schizophrenia?
  by saleemasraf
What Is Schizophrenia? Although an exact definition of schizophrenia still evades medical researchers, the evidence indicates more and more strongly that schizophrenia is a severe […]


Two minute overview of antipsychotics
  by May Su
Original article by: May Su :: Printer friendly Antipsychotics can be classified as typical or atypical. There are very few reasons now where a typical would be used in […]


DSM-V: Jumping the gun?
  by SearchMedica
As the diagnostic field trials wait in the wings, critics argue that the process to create DSM-V is too secretive and too hurried. It's easy to follow the unfolding […]


Are the Feds Blocking Medical Marijuana Research?
  by editors
See Also: New York Times Exposes Government Conspiracy to Prevent Medical Marijuana Research (Source: MyFoxAtlanta)  About eight out of 10 Americans favor legalizing marijuana for medicinal use. Fourteen states […]


PDF DOWNLOAD A Guide to Psychotropic Drugs
  by labvirus
http://www.mhri.edu.au/pdf/A%20GUIDE%20TO%20PSYCHOTROPIC%20DRUGS.pdf ANTIPSYCHOTICS (Neuroleptics, Major Tranquillisers) What do they do? Antipsychotics are used principally in the treatment of psychoses. They diminish the agitation, delusions, hallucinations and thought disorder of these illnesses. The drugs […]


Risperdal alternative use
  by pirutexas
All results may treat behavior talks, but big months have no, or hepatic, reaction patients. Any crackhead used with psychotic antipsychotics should be used for talks of prolactin […]


It looks as if the US government is stocking up on Meds in preparation for War with Iran, possibly Russia and China
  by megaelements
Recently the FDA released a list of drugs that are in short supply. It can only be concluded that the US government has requested and […]


Risperdal is
  by pazuready
And my horrible choice everything will also have troubled me shows else and this was even a psychotic myalgia. The making mother includes only the sexual movements of […]


Pharmacological interventions for borderline personality disorder - Cochrane
  by sjennings29
Pharmacological interventions for borderline personality disorder, 16 JUN 2010, DOI : 10.1002/14651858.CD005653 Click on the title to access the direct full-text link The Cochrane Library Jutta Stoffers, Birgit A Völlm, Gerta […]


We may see, as lately rema
  by ydetmlhnvdq
7:17 Even so every good tree bringeth forth good fruit; but a corrupt tree bringeth forth evil fruit. Fauvel put his arm around Chases shoulders and walked him […]



Other reviews about Haloperidol Decanoate on web:

The decanoate ester of haloperidol (Haloperidol decanoate, trade names Haldol decanoate, Halomonth, Neoperidole) has a much longer duration of action, and therefore is often used in ... Haloperidol - Wikipedia, the free encyclopedia


All about Haloperidol Decanoate. View complete and up to date Haloperidol Decanoate information - part of the Drugs.com trusted medication database. Haloperidol Decanoate Facts and Comparisons at Drugs.com


Learn about the prescription medication Haldol Decanoate (Haloperidol Decanoate), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Haldol Decanoate (Haloperidol Decanoate) Drug Information: Uses ...


Consumer information about the medication HALOPERIDOL DECANOATE - INTRAMUSCULAR INJECTION (Haldol), includes side effects, drug interactions, recommended dosages, and storage ... HALOPERIDOL DECANOATE - INTRAMUSCULAR INJECTION (Haldol) side ...


Although the long-acting properties of haloperidol decanoate provide gradual withdrawal, it is not known whether gradual withdrawal of antipsychotic drugs will reduce the rate of ... Haldol Decanoate Official FDA information, side effects and uses.


Haloperdol ( Haldol, Haldol Decanoate, Halperon ) data sheet ... Haloperidol ( Haldol, Haldol Decanoate, Halperon ) ( In Canada ( Apo-Haloperidol, Haldol LA, Novo-Peridol, Peridol, PMS ... Haloperidol ( Haldol, Haldol Decanoate ) data sheet


haloperidol/haloperidol decanoate n trade name: Haldol; drug class: antipsychotic/butyrophenone; action: blocks neurotransmission at dopaminergic haloperidol/haloperidol decanoate: Definition from Answers.com


Haloperidol Decanoate is an antipsychotic agent used to treat schizophrenia. Side effects and interactions are available at drugstore.com; plus get home delivery from a trusted and ... Haloperidol Decanoate - drugstore.com. Low prices, side effects ...


Find patient medical information for Haloperidol Decanoate IM on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Haloperidol Decanoate IM : Uses, Side Effects, Interactions ...


Haloperidol decanoate. Latin name. The composition and the form of production. Description. Pharmacokinetics. Farmakodinamika. Indications. Pregnancy and lactation. Haloperidol decanoate





Featured Reviews

Reviews Etodolac XR

Etodolac XR Drug Description Etodolac XR (etodolac) Extended-Release Tablets Cardiovascular Risk NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be...
Read More  |  Review This
Reviews Albumin

Albuminar Drug Description Albuminar®-25 [albumin (Human)] USP, 25% DRUG DESCRIPTION Albumin (Human) 25%, Albuminar®-25 is a sterile aqueous solution of albumin obtained from large pools of adult human venous plasma by low temperature...
Read More  |  Review This
Reviews Brimonidine Tartrate, Timolol Maleate Ophthalmic Solution .2%/.5%

Combigan Drug Description COMBIGAN™ (brimonidine tartrate/timolol maleate ophthalmic solution 0.2%/0.5%) DRUG DESCRIPTION What are the possible side effects of brimonidine and timolol ophthalmic (Combigan)? Get emergency...
Read More  |  Review This
Reviews Axid

Axid Drug Description AXID® (nizatidine) Capsules, USP DRUG DESCRIPTION What are the possible side effects of nizatidine (Axid AR, Axid Pulvules)? If you experience any of the following serious side effects, stop taking nizatidine...
Read More  |  Review This
Reviews Nicotrol

Nicotrol Drug Description NICOTROL® (nicotine) Inhalant DRUG DESCRIPTION What are the possible side effects of nicotine? Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing;...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....